Literature DB >> 16948964

Clinical inquiries. What test is the best for diagnosing infectious mononucleosis?

Amy Trelease Bell1, Barbara Fortune, Robert Sheeler.   

Abstract

Tests for antibodies to Epstein-Barr viral capsid antigen or Epstein-Barr nuclear antigen are the most sensitive, are highly specific, and are also the most expensive for diagnosing infectious mononucleosis (strength of recommendation [SOR]: C, based on validating cohort study). Heterophile antibody tests have similar specificity and are cheaper, but are less sensitive in children or in adults during the early days of the illness (SOR: C, based on validating cohort study). The polymerase chain reaction assay for Epstein-Barr virus DNA is more sensitive than the heterophile antibody test in children, is highly specific, but is also expensive (SOR: C, based on validating cohort study). The percentages of atypical lymphocytes and total lymphocytes on a complete blood count provide another specific and moderately sensitive, yet inexpensive, test (SOR: C, based on validating cohort study).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16948964

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  4 in total

1.  Erythema multiforme-like lesions in the course of infectious mononucleosis.

Authors:  Vijay Zawar; Antonio Chuh; Sudhir Sankalecha
Journal:  J Dermatol Case Rep       Date:  2009-11-28

Review 2.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

3.  Possible infectious causes of spontaneous splenic rupture: a case report.

Authors:  Grace Y Lam; Adrienne K Chan; Jeff E Powis
Journal:  J Med Case Rep       Date:  2014-11-30

4.  Comparison of serological and molecular test for diagnosis of infectious mononucleosis.

Authors:  Hassan Salehi; Marziyeh Salehi; Rasoul Roghanian; Majid Bozari; Shirin Taleifard; Mohamad Mahdi Salehi; Maryam Salehi
Journal:  Adv Biomed Res       Date:  2016-05-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.